Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q1
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
aggressive, azacitidine, chromatin, chronic, classification, comprised, currency, death, detachable, embedded, endometrial, fixed, freestanding, gene, Hedging, instrument, lymphocytic, mantle, MCL, mutated, mutation, poor, remodeling, repurchase, Richter, simplified, sparing, Subtopic, survival, twelve, venetoclax, vi, warrant, zanubrutinib
Valuein 2023 Q1 filing- Value in 2023 Q1 filing
Original filings
Filing view